Magazine

Returning to Play: The Evolution of Cardiac Guidelines for Athletes with COVID-19

Our understanding of COVID-19 has evolved greatly since its first appearance in the U.S. in early 2020. Though our knowledge remains incomplete, we’ve learned a lot about the pathophysiology of the virus—especially its unique effects on the heart.

Oasis of Opportunity: Strategies for Managing Healthcare’s Data Deluge

Forward-looking providers are converting reams of data from myriad sources into innovative new ways to deliver healthcare and improve efficiencies.

Stirring the Pot: Cannabis & Cardiology—How & Why to Talk with Patients About Marijuana Use

As use of cannabis products increases and evidence of possible cardiovascular harm mounts, it’s time for cardiologists to start having conversations with their patients.

Pop Goes the Pillbox: Will Polypharmacy Problems Limit the Adoption of SGLT2 Inhibitors?

Following data supporting their use for heart failure and type 2 diabetes, will sodium-glucose cotransporter 2 inhibitors find a spot in the heart failure armamentarium?

90 Days a Dyad (or Triad): Strategies for Success & Errors to Avoid in the Crucial Early Days of Partnership

Experienced dyad and triad partners share tips for setting the stage for success and putting the brakes on mistakes.

New Take on Transplant: Reconsidering Hepatitis C-infected Hearts for Donation

As many as 700 hearts from donors with hepatitis C are discarded each year in the U.S. New research suggests at least some of these organs may be suitable for transplant.

Whether Actionable or Adorable, Data Takes Patience (& Patient-centeredness)

Even the best analytics won’t replace human interaction; protect your time with patients and colleagues. Focus on the patient-centered metrics, and try to be patient. It takes time to turn a mess into a masterpiece.

Data Dilemma: Taming Healthcare’s Beautiful Beast

To get the operational perspective, CVB hosted a roundtable discussion with service line leaders about the opportunities and challenges they encounter around data.

An Invitation: To Tackle Social Determinants of Health, Stray From Your Lane

I don’t need to tell you that social determinants of health (SDoH) present challenges for your patients. You’ve seen the data indicating that as much as 80 percent of an individual’s health comes from factors other than the clinical care he or she receives. You know the impact of disparities.

Innovations & Interventions: ACC.19 Will Explore the ‘World of Cardiology’

ACC.19 will feature 36 late-breaking clinical trials and clinical research studies, starting with the Apple Heart Study’s findings on the ability of a smartwatch to help identify atrial fibrillation. That question is just one of many the conference will address, says ACC.19 Program Chair Andrew Kates, MD, professor of medicine and director of the cardiology fellowship program at Washington University School of Medicine in St. Louis. During a conversation with Cardiovascular Business, Kates predicted trial highlights and previewed some ACC.19 program innovations.

Coronary Artery Calcium Scanning Is Not a Magic 8 Ball

Coronary artery calcium scanning is not a Magic 8 Ball, but it is a powerful predictor and a valuable tool for cardiology practices.

Playing the Long Game: Connect & Collaborate to Tackle Social Determinants of Health

Addressing social determinants of health improves outcomes, possibly providing a return on investment. Margins matter, but it’s a long game, often driven by a sense of mission.